1. Home
  2. IINN vs CASI Comparison

IINN vs CASI Comparison

Compare IINN & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IINN
  • CASI
  • Stock Information
  • Founded
  • IINN 2018
  • CASI 1991
  • Country
  • IINN Israel
  • CASI China
  • Employees
  • IINN N/A
  • CASI N/A
  • Industry
  • IINN Medical/Dental Instruments
  • CASI Biotechnology: Pharmaceutical Preparations
  • Sector
  • IINN Health Care
  • CASI Health Care
  • Exchange
  • IINN Nasdaq
  • CASI Nasdaq
  • Market Cap
  • IINN 34.1M
  • CASI 35.8M
  • IPO Year
  • IINN 2021
  • CASI 1996
  • Fundamental
  • Price
  • IINN $1.25
  • CASI $2.34
  • Analyst Decision
  • IINN Strong Buy
  • CASI Strong Buy
  • Analyst Count
  • IINN 1
  • CASI 1
  • Target Price
  • IINN $2.00
  • CASI $4.00
  • AVG Volume (30 Days)
  • IINN 1.5M
  • CASI 403.1K
  • Earning Date
  • IINN 09-19-2025
  • CASI 08-29-2025
  • Dividend Yield
  • IINN N/A
  • CASI N/A
  • EPS Growth
  • IINN N/A
  • CASI N/A
  • EPS
  • IINN N/A
  • CASI N/A
  • Revenue
  • IINN N/A
  • CASI $31,564,000.00
  • Revenue This Year
  • IINN N/A
  • CASI N/A
  • Revenue Next Year
  • IINN $2,050.00
  • CASI N/A
  • P/E Ratio
  • IINN N/A
  • CASI N/A
  • Revenue Growth
  • IINN N/A
  • CASI 36.64
  • 52 Week Low
  • IINN $0.40
  • CASI $1.09
  • 52 Week High
  • IINN $1.65
  • CASI $7.67
  • Technical
  • Relative Strength Index (RSI)
  • IINN 54.38
  • CASI 59.07
  • Support Level
  • IINN $1.11
  • CASI $2.18
  • Resistance Level
  • IINN $1.23
  • CASI $2.46
  • Average True Range (ATR)
  • IINN 0.08
  • CASI 0.24
  • MACD
  • IINN 0.00
  • CASI -0.02
  • Stochastic Oscillator
  • IINN 50.00
  • CASI 60.94

About IINN Inspira Technologies Oxy B.H.N. Ltd.

Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Share on Social Networks: